Description
Tirzepatide — dual GIP/GLP-1 agonist
Tirzepatide is a dual-agonist peptide targeting the GIP and GLP-1 receptors, studied in laboratory research on incretin signalling and metabolic models. It is supplied as a research-grade lyophilized powder for in-vitro and preclinical study.
Research Applications
- GIP and GLP-1-receptor binding assays
- Incretin- and glucose-metabolism models
- Peptide-stability and half-life research
Research Information
Purity
99%+ (HPLC Verified)
Molecular Formula
C225H348N48O68
Molecular Weight
4813.45 g/mol
Form
Lyophilized Powder
Storage
Store lyophilized material at -20°C
Documentation
COA Available
For Research Use Only
This product is intended strictly for laboratory and scientific research. Not for human or veterinary use. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the buyer confirms they are a verified research business and will comply with all applicable laws.
Reviews
There are no reviews yet.